Radiofrequency ablation of advanced head and neck cancer

Randall P. Owen, Sajid A. Khan, Abdissa Negassa, Jonathan J. Beitler, Jacqueline A. Bello, Allan Brook, Joaquim Farinhas, Madhur K. Garg, Missak Haigentz, Todd S. Miller, Melody S. Hsu, Thanjuvar S. Ravikumar, Keivan Shifteh, Richard V. Smith, Carl E. Silver

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Objective: To determine if the application of radiofrequency ablation to advanced head and neck cancer (HNC) would result in local control of the tumor. Design: Radiofrequency ablation was applied to advanced head and neck malignant tumors in the participants of this nonrandomized controlled trial. Setting: Academic tertiary care medical center. Participants: Twenty-one participants with recurrent and/or unresectable HNC who failed treatment with surgery, radiation, and/or chemotherapy were selected for the trial. Patients deemed appropriate for curative standard radiation or surgery were not accepted as participants. Intervention: Radiofrequency ablation was applied to head and neck tumors under general anesthesia and computed tomographic scan guidance. Main Outcome Measures: The primary end point was local control. Computed tomographic scan tumor measurements were used to assess response by standard response evaluation criteria in solid tumors (RECIST) guidelines. Secondary outcome measures included survival and quality of life. Results: Eight of 13 participants had stable disease after intervention. Median survival was 127 days, and an improvement in University of Washington quality-of-life scores was noted. Adverse outcomes included 1 death due to carotid hemorrhage and 2 strokes. Conclusion: Radiofrequency ablation is a palliative treatment alternative that shows promise in addressing the challenges of local control and quality of life in patients with incurable HNC who have failed standard curative treatment.

Original languageEnglish (US)
Pages (from-to)493-498
Number of pages6
JournalArchives of Otolaryngology - Head and Neck Surgery
Volume137
Issue number5
DOIs
StatePublished - May 1 2011
Externally publishedYes

Fingerprint

Head and Neck Neoplasms
Quality of Life
Neoplasms
Neck
Head
Outcome Assessment (Health Care)
Radiation
Survival
Palliative Care
Tertiary Care Centers
General Anesthesia
Stroke
Guidelines
Hemorrhage
Drug Therapy
Therapeutics

All Science Journal Classification (ASJC) codes

  • Surgery
  • Otorhinolaryngology

Cite this

Owen, R. P., Khan, S. A., Negassa, A., Beitler, J. J., Bello, J. A., Brook, A., ... Silver, C. E. (2011). Radiofrequency ablation of advanced head and neck cancer. Archives of Otolaryngology - Head and Neck Surgery, 137(5), 493-498. https://doi.org/10.1001/archoto.2011.62
Owen, Randall P. ; Khan, Sajid A. ; Negassa, Abdissa ; Beitler, Jonathan J. ; Bello, Jacqueline A. ; Brook, Allan ; Farinhas, Joaquim ; Garg, Madhur K. ; Haigentz, Missak ; Miller, Todd S. ; Hsu, Melody S. ; Ravikumar, Thanjuvar S. ; Shifteh, Keivan ; Smith, Richard V. ; Silver, Carl E. / Radiofrequency ablation of advanced head and neck cancer. In: Archives of Otolaryngology - Head and Neck Surgery. 2011 ; Vol. 137, No. 5. pp. 493-498.
@article{6e217defb4534944a34b3725b118b6e0,
title = "Radiofrequency ablation of advanced head and neck cancer",
abstract = "Objective: To determine if the application of radiofrequency ablation to advanced head and neck cancer (HNC) would result in local control of the tumor. Design: Radiofrequency ablation was applied to advanced head and neck malignant tumors in the participants of this nonrandomized controlled trial. Setting: Academic tertiary care medical center. Participants: Twenty-one participants with recurrent and/or unresectable HNC who failed treatment with surgery, radiation, and/or chemotherapy were selected for the trial. Patients deemed appropriate for curative standard radiation or surgery were not accepted as participants. Intervention: Radiofrequency ablation was applied to head and neck tumors under general anesthesia and computed tomographic scan guidance. Main Outcome Measures: The primary end point was local control. Computed tomographic scan tumor measurements were used to assess response by standard response evaluation criteria in solid tumors (RECIST) guidelines. Secondary outcome measures included survival and quality of life. Results: Eight of 13 participants had stable disease after intervention. Median survival was 127 days, and an improvement in University of Washington quality-of-life scores was noted. Adverse outcomes included 1 death due to carotid hemorrhage and 2 strokes. Conclusion: Radiofrequency ablation is a palliative treatment alternative that shows promise in addressing the challenges of local control and quality of life in patients with incurable HNC who have failed standard curative treatment.",
author = "Owen, {Randall P.} and Khan, {Sajid A.} and Abdissa Negassa and Beitler, {Jonathan J.} and Bello, {Jacqueline A.} and Allan Brook and Joaquim Farinhas and Garg, {Madhur K.} and Missak Haigentz and Miller, {Todd S.} and Hsu, {Melody S.} and Ravikumar, {Thanjuvar S.} and Keivan Shifteh and Smith, {Richard V.} and Silver, {Carl E.}",
year = "2011",
month = "5",
day = "1",
doi = "10.1001/archoto.2011.62",
language = "English (US)",
volume = "137",
pages = "493--498",
journal = "JAMA Otolaryngology - Head and Neck Surgery",
issn = "2168-6181",
publisher = "American Medical Association",
number = "5",

}

Owen, RP, Khan, SA, Negassa, A, Beitler, JJ, Bello, JA, Brook, A, Farinhas, J, Garg, MK, Haigentz, M, Miller, TS, Hsu, MS, Ravikumar, TS, Shifteh, K, Smith, RV & Silver, CE 2011, 'Radiofrequency ablation of advanced head and neck cancer', Archives of Otolaryngology - Head and Neck Surgery, vol. 137, no. 5, pp. 493-498. https://doi.org/10.1001/archoto.2011.62

Radiofrequency ablation of advanced head and neck cancer. / Owen, Randall P.; Khan, Sajid A.; Negassa, Abdissa; Beitler, Jonathan J.; Bello, Jacqueline A.; Brook, Allan; Farinhas, Joaquim; Garg, Madhur K.; Haigentz, Missak; Miller, Todd S.; Hsu, Melody S.; Ravikumar, Thanjuvar S.; Shifteh, Keivan; Smith, Richard V.; Silver, Carl E.

In: Archives of Otolaryngology - Head and Neck Surgery, Vol. 137, No. 5, 01.05.2011, p. 493-498.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Radiofrequency ablation of advanced head and neck cancer

AU - Owen, Randall P.

AU - Khan, Sajid A.

AU - Negassa, Abdissa

AU - Beitler, Jonathan J.

AU - Bello, Jacqueline A.

AU - Brook, Allan

AU - Farinhas, Joaquim

AU - Garg, Madhur K.

AU - Haigentz, Missak

AU - Miller, Todd S.

AU - Hsu, Melody S.

AU - Ravikumar, Thanjuvar S.

AU - Shifteh, Keivan

AU - Smith, Richard V.

AU - Silver, Carl E.

PY - 2011/5/1

Y1 - 2011/5/1

N2 - Objective: To determine if the application of radiofrequency ablation to advanced head and neck cancer (HNC) would result in local control of the tumor. Design: Radiofrequency ablation was applied to advanced head and neck malignant tumors in the participants of this nonrandomized controlled trial. Setting: Academic tertiary care medical center. Participants: Twenty-one participants with recurrent and/or unresectable HNC who failed treatment with surgery, radiation, and/or chemotherapy were selected for the trial. Patients deemed appropriate for curative standard radiation or surgery were not accepted as participants. Intervention: Radiofrequency ablation was applied to head and neck tumors under general anesthesia and computed tomographic scan guidance. Main Outcome Measures: The primary end point was local control. Computed tomographic scan tumor measurements were used to assess response by standard response evaluation criteria in solid tumors (RECIST) guidelines. Secondary outcome measures included survival and quality of life. Results: Eight of 13 participants had stable disease after intervention. Median survival was 127 days, and an improvement in University of Washington quality-of-life scores was noted. Adverse outcomes included 1 death due to carotid hemorrhage and 2 strokes. Conclusion: Radiofrequency ablation is a palliative treatment alternative that shows promise in addressing the challenges of local control and quality of life in patients with incurable HNC who have failed standard curative treatment.

AB - Objective: To determine if the application of radiofrequency ablation to advanced head and neck cancer (HNC) would result in local control of the tumor. Design: Radiofrequency ablation was applied to advanced head and neck malignant tumors in the participants of this nonrandomized controlled trial. Setting: Academic tertiary care medical center. Participants: Twenty-one participants with recurrent and/or unresectable HNC who failed treatment with surgery, radiation, and/or chemotherapy were selected for the trial. Patients deemed appropriate for curative standard radiation or surgery were not accepted as participants. Intervention: Radiofrequency ablation was applied to head and neck tumors under general anesthesia and computed tomographic scan guidance. Main Outcome Measures: The primary end point was local control. Computed tomographic scan tumor measurements were used to assess response by standard response evaluation criteria in solid tumors (RECIST) guidelines. Secondary outcome measures included survival and quality of life. Results: Eight of 13 participants had stable disease after intervention. Median survival was 127 days, and an improvement in University of Washington quality-of-life scores was noted. Adverse outcomes included 1 death due to carotid hemorrhage and 2 strokes. Conclusion: Radiofrequency ablation is a palliative treatment alternative that shows promise in addressing the challenges of local control and quality of life in patients with incurable HNC who have failed standard curative treatment.

UR - http://www.scopus.com/inward/record.url?scp=79956106680&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79956106680&partnerID=8YFLogxK

U2 - 10.1001/archoto.2011.62

DO - 10.1001/archoto.2011.62

M3 - Article

VL - 137

SP - 493

EP - 498

JO - JAMA Otolaryngology - Head and Neck Surgery

JF - JAMA Otolaryngology - Head and Neck Surgery

SN - 2168-6181

IS - 5

ER -

Owen RP, Khan SA, Negassa A, Beitler JJ, Bello JA, Brook A et al. Radiofrequency ablation of advanced head and neck cancer. Archives of Otolaryngology - Head and Neck Surgery. 2011 May 1;137(5):493-498. https://doi.org/10.1001/archoto.2011.62